Summary:
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Determine the Efficacy and Safety of Once Daily Centanafadine Capsules for the Treatment of Adolescents With Attention-deficit/Hyperactivity Disorde
11 study visits will be required over a 12 week period
Qualified Participants Must:
Adolescents must be between the ages of 13-17
Suffering from ADHD symptoms (your child does not need to be diagnosed to be considered for this study)
Must be willing to attend the study office visits and complete all study assessments.
After the completion of this study, your child may qualify to participate in an open label long term study where they will receive the actual study medication and not a placebo
Qualified Participants May Receive:
-Reimbursement for time and travel of $75 will be provided per study visit
-Free study related medication and study related doctor visits
-Transportation may be provided